Citation: Vr. Bulusu, CORRESPONDENCE RE - CASERINI,C. ET-AL., APOPTOSIS AS A DETERMINANT OFTUMOR SENSITIVITY TO TOPOTECAN IN HUMAN OVARIAN-TUMORS - PRECLINICAL IN VITROLIN VIVO STUDIES, Clinical cancer research, 4(1), 1998, pp. 261-262
Citation: Vr. Bulusu, CORRESPONDENCE RE - CASERINI,C. ET-AL., APOPTOSIS AS A DETERMINANT OFTUMOR SENSITIVITY TO TOPOTECAN IN HUMAN OVARIAN-TUMORS - PRECLINICAL IN VITROLIN VIVO STUDIES, Clinical cancer research, 4(1), 1998, pp. 261-262
Citation: Vr. Bulusu et al., ORAL ETOPOSIDE AND CONTINUOUS 5-FU INFUSION IN RECURRENT EPITHELIAL OVARIAN-CANCER, European journal of cancer, 34, 1998, pp. 102-102
Citation: Jv. Watson et al., SEQUENTIAL TOPOTECAN (TOPOISOMERASE-I INHIBITOR) AND ETOPOSIDE (TOPOISOMERASE-II INHIBITOR) IN ADVANCED, ADULT SOLID TUMORS, British Journal of Cancer, 78, 1998, pp. 37-37
Authors:
PRATT J
BROOK J
DEZEEUW N
BULUSU VR
WETHERALL A
WILLIAMS MV
Citation: J. Pratt et al., EVALUATION OF A STANDARD FOR EMOTIONAL SUPPORT FOR OUTPATIENTS IN A REGIONAL CANCER CENTER IN THE UK, European journal of cancer, 33, 1997, pp. 1396-1396
Authors:
DEZEEUW N
BULUSU VR
THOMAS R
OWEN C
BAINES H
ALLERTON R
Citation: N. Dezeeuw et al., CANCER-PATIENT EDUCATION AND INFORMATION - DEVELOPMENT OF A NEW STRUCTURED INFORMATION PACKAGE, European journal of cancer, 33, 1997, pp. 1400-1400
Citation: Vr. Bulusu, PACLITAXEL IN RECURRENT OVARIAN-CANCER - BETTER UPFRONT - COMMENTS ON- A PHASE-II STUDY OF PACLITAXEL IN PLATINUM PRETREATED OVARIAN-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, European journal of cancer, 33(11), 1997, pp. 1905-1906